<DOC>
	<DOCNO>NCT02215395</DOCNO>
	<brief_summary>To evaluate pharmacokinetics ( PK ) EE NES release CVR presence single dose multiple dos antimycotic co-medication ( miconazole nitrate suppository cream ) .</brief_summary>
	<brief_title>An Open-label Study Evaluate Effects Concurrent Administration Vaginal Antimycotic Medication Miconazole Nitrate Pharmacokinetics Nestorone Ethinyl Estradiol Delivered Contraceptive Vaginal Ring Normal Ovulating Women</brief_title>
	<detailed_description />
	<mesh_term>Drug-Related Side Effects Adverse Reactions</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>ST 1435</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<criteria>Healthy woman , inclusive age 1835* year enrollment visit Intact uterus ovary Prior history regular menstrual cycle usually occur every 28 Â± 7 day use hormonal contraception ; postpartum postabortal , history regular menstrual cycle 2135 day length resumption least one cycle cycle length consistent past cycle In opinion investigator , able comply protocol , e.g . live within study site catchment area within reasonable distance study site May sterilize risk become pregnant Willing use nonhormonal method contraception one month prior initial insertion NES/EE CVR one month washout period Willing abstain sexual intercourse miconazole nitrate treatment period ( ) Signed informed consent prior entry trial Known hypersensitivity estrogens progestin Pregnant , try become pregnant , breastfeed Known hypersensitivity silicone rubber Undiagnosed abnormal vaginal bleeding Undiagnosed vaginal discharge , vaginal lesion abnormality . Subjects diagnose screen Chlamydia gonococcus infection may include trial follow treatment ; partner treatment also recommend . Investigators make determination subject high risk reinfection , e.g. , multiple sex partner , untreated partner , whether subject include History pelvic inflammatory disease since subject 's last pregnancy History toxic shock syndrome In accordance Bethesda system classification : Women current ( within last 20 month ) abnormal Pap smear suggestive highgrade precancerous lesion ( ) , include HGSIL Cystoceles rectoceles anatomical abnormality would preclude use vaginal ring Women plan undergo major surgery trial Women smoke 15 cigarette per day must evaluate PI inclusion base risk factor would increase risk cardiovascular disease thromboembolism , e.g. , lipid level , glucose level , BP , BMI , family history cardiovascular disease young age Current past thrombophlebitis thromboembolic disorder History venous thrombosis embolism firstdegree relative , &lt; 55 year age suggest familial defect blood coagulation system , opinion PI , suggest use hormonal contraceptive could pose significant risk Cerebrovascular cardiovascular disease History retinal vascular lesion , unexplained partial complete loss vision Known suspect carcinoma breast Carcinoma endometrium know suspected estrogendependent neoplasia Past history carcinoma unless remission five year Current history medically diagnose severe depression , , opinion investigator , could exacerbate use hormonal contraceptive Headaches focal neurological symptom Severe constipation opinion investigator History cholestatic jaundice pregnancy jaundice prior steroid use Benign malignant liver tumor ; active liver disease Diastolic blood pressure ( BP ) &gt; 85 mm Hg and/or systolic BP &gt; 135 mm Hg 510 minute rest ( screen ) Known suspect alcoholism drug abuse within lifetime Elevated serum fast clinical chemistry value complete blood count ( CBC ) value designate clinically significant investigator and/or medically qualify subinvestigator Screening hemoglobin level less 12.5 g/dL hematocrit le 38 % . Participation another clinical trial involve investigational drug within last 30 day ( prior screening ) BMI &gt; 29 Use liver enzyme inducer regular basis Use monthly injectable contraceptive , unless suspend 2 month initiation treatment . Use DepoProvera [ depomedroxyprogesterone ( DMPA ) ] unless suspend 6 month treatment Current use implant hormonal contraceptive , include Mirena [ progestin contain intrauterine system ( IUS ) ] , Jadelle , Norplant , Implanon Nexplanon ( available USA ) . ** Known HIV , Hepatitis B Hepatitis C infection History frequent vaginal infection opinion investigator</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Nestorone</keyword>
	<keyword>miconazole nitrate</keyword>
</DOC>